Sygnature Discovery

News

Just a few months after emerging from stealth, the UK's DaltonTx has launched its AI in drug discovery platform and revealed its first client.

News

Shares in ADC Therapeutics fell more than 50% after a non-Hodgkin lymphoma trial showed more deaths with its Zynlonta drug compared to a control.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.